Adolescent Outcomes of Post-operative Opioid EXposure
NCT06350409 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000
Last updated 2026-03-18
Summary
The goal of this observational study is to examine the factors associated with the transition from medical exposure to opioids with "signposts" of future opioid use disorder among adolescent surgical patients. The main question aims to identify factors (moderators, mediators, and covariates) associated with risk factors for opioid use disorder (ROUD) in the 12 months following major surgery with opioid exposure among adolescents aged 12-17. Participants will be asked to complete electronic surveys pre- and post-operatively and approve the collection of peri-operative data from the Electronic Medical Record to assess correlations.
Conditions
- Opioid Use Disorder
- Pain, Chronic
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
National Institutes of Health (NIH)
collaborator NIH -
Sharon Levy
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-12
- Primary Completion
- 2028-02-29
- Completion
- 2028-02-29
Countries
- United States
Study Locations
More Related Trials
-
Extended Release Naltrexone for Opioid-Dependent Youth
NCT01843023 ·Status: COMPLETED ·Phase: PHASE4
-
Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD
NCT03635346 ·Status: COMPLETED
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Health Outcomes From Opioid Therapy for Chronic Pain
NCT00495404 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083 ·Status: COMPLETED ·Phase: PHASE3
-
Safe Opioid Prescription Practice for Patients Discharged From Trauma Services
NCT02584881 ·Status: UNKNOWN ·Phase: NA
-
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902 ·Status: ENROLLING_BY_INVITATION
-
PO Methadone Ortho Outpatient
NCT06351215 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone
NCT03306368 ·Status: COMPLETED ·Phase: NA
-
Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
NCT00315835 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
NCT04981678 ·Status: TERMINATED ·Phase: PHASE4
-
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
NCT02360371 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
NCT01642030 ·Status: COMPLETED ·Phase: PHASE1
-
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
NCT02136784 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
NCT04464980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Aprepitant Effects on Oxycodone Response
NCT00999544 ·Status: COMPLETED ·Phase: NA
-
Pain and Opioid Management in Older Adults
NCT05037682 ·Status: RECRUITING ·Phase: NA
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
NCT06995885 ·Status: ENROLLING_BY_INVITATION